AI
Therapeutic Areas
6S Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Innovation Portfolio (505(b)(2)) | Oncology (specifics undisclosed) | Pre-clinical |
| Generic Portfolio (Complex Generics) | Not Applicable (Generic) | Pre-ANDA |
| Drug | Indication | Phase |
|---|---|---|
| Innovation Portfolio (505(b)(2)) | Oncology (specifics undisclosed) | Pre-clinical |
| Generic Portfolio (Complex Generics) | Not Applicable (Generic) | Pre-ANDA |